LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 305

Search options

  1. Article ; Online: Fascin lysine 471 acetylation cooperates with serine 39 phosphorylation to inhibit actin-bundling activity and tumor metastasis in esophageal squamous cell carcinoma.

    Zeng, Fa-Min / Cheng, Yin-Wei / He, Jian-Zhong / Xu, Xiu-E / Liao, Lian-Di / Xu, Li-Yan / Li, En-Min

    Cancer communications (London, England)

    2022  Volume 42, Issue 7, Page(s) 668–672

    MeSH term(s) Acetylation ; Actins/metabolism ; Carrier Proteins ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma ; Humans ; Lysine ; Microfilament Proteins ; Phosphorylation ; Serine/metabolism
    Chemical Substances Actins ; Carrier Proteins ; Microfilament Proteins ; fascin (146808-54-0) ; Serine (452VLY9402) ; Lysine (K3Z4F929H6)
    Language English
    Publishing date 2022-05-06
    Publishing country United States
    Document type Letter ; Research Support, Non-U.S. Gov't
    ISSN 2523-3548
    ISSN (online) 2523-3548
    DOI 10.1002/cac2.12297
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.

    He, Jian-Zhong / Chen, Yang / Zeng, Fa-Min / Huang, Qing-Feng / Zhang, Hai-Feng / Wang, Shao-Hong / Yu, Shuai-Xia / Pang, Xiao-Xiao / Liu, Ye / Xu, Xiu-E / Wu, Jian-Yi / Shen, Wen-Jun / Li, Zhan-Yu / Li, En-Min / Xu, Li-Yan

    Journal of experimental & clinical cancer research : CR

    2023  Volume 42, Issue 1, Page(s) 136

    Abstract: Background: Increasing evidence indicates that the tumor microenvironment (TME) is a crucial determinant of cancer progression. However, the clinical and pathobiological significance of stromal signatures in the TME, as a complex dynamic entity, is ... ...

    Abstract Background: Increasing evidence indicates that the tumor microenvironment (TME) is a crucial determinant of cancer progression. However, the clinical and pathobiological significance of stromal signatures in the TME, as a complex dynamic entity, is still unclear in esophageal squamous cell carcinoma (ESCC).
    Methods: Herein, we used single-cell transcriptome sequencing data, imaging mass cytometry (IMC) and multiplex immunofluorescence staining to characterize the stromal signatures in ESCC and evaluate their prognostic values in this aggressive disease. An automated quantitative pathology imaging system determined the locations of the lamina propria, stroma, and invasive front. Subsequently, IMC spatial analyses further uncovered spatial interaction and distribution. Additionally, bioinformatics analysis was performed to explore the TME remodeling mechanism in ESCC. To define a new molecular prognostic model, we calculated the risk score of each patient based on their TME signatures and pTNM stages.
    Results: We demonstrate that the presence of fibroblasts at the tumor invasive front was associated with the invasive depth and poor prognosis. Furthermore, the amount of α-smooth muscle actin (α-SMA)
    Conclusions: Our newly defined biomarker signature may serve as a complement for current clinical risk stratification approaches and provide potential therapeutic targets for reversing the fibroblast-mediated immunosuppressive microenvironment.
    MeSH term(s) Humans ; Esophageal Neoplasms/metabolism ; Esophageal Squamous Cell Carcinoma/pathology ; Carcinoma, Squamous Cell/pathology ; CD8-Positive T-Lymphocytes/metabolism ; Prognosis ; Fibroblasts/metabolism ; Tumor Microenvironment
    Language English
    Publishing date 2023-05-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 803138-1
    ISSN 1756-9966 ; 0392-9078
    ISSN (online) 1756-9966
    ISSN 0392-9078
    DOI 10.1186/s13046-023-02697-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes

    Fa‐Min Zeng / Ying‐wen Li / Zhao‐hua Deng / Jian‐zhong He / Wei Li / Lijie Wang / Ting Lyu / Zhanyu Li / Chaoming Mei / Meiling Yang / Yingying Dong / Guan‐Min Jiang / Xiaofeng Li / Xi Huang / Fei Xiao / Ye Liu / Hong Shan / Huanhuan He

    EMBO Molecular Medicine, Vol 14, Iss 5, Pp n/a-n/a (2022)

    2022  

    Abstract: Abstract Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) can cause gastrointestinal (GI) symptoms that often correlate with the severity of COVID‐19. Here, we explored the pathogenesis underlying the intestinal inflammation in COVID‐19. ... ...

    Abstract Abstract Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) can cause gastrointestinal (GI) symptoms that often correlate with the severity of COVID‐19. Here, we explored the pathogenesis underlying the intestinal inflammation in COVID‐19. Plasma VEGF level was particularly elevated in patients with GI symptoms and significantly correlated with intestinal edema and disease progression. Through an animal model mimicking intestinal inflammation upon stimulation with SARS‐CoV‐2 spike protein, we further revealed that VEGF was over‐produced in the duodenum prior to its ascent in the circulation. Mechanistically, SARS‐CoV‐2 spike promoted VEGF production through activating the Ras‐Raf‐MEK‐ERK signaling in enterocytes, but not in endothelium, and inducing permeability and inflammation. Blockage of the ERK/VEGF axis was able to rescue vascular permeability and alleviate intestinal inflammation in vivo. These findings provide a mechanistic explanation and therapeutic targets for the GI symptoms of COVID‐19.
    Keywords COVID‐19 ; GI symptoms ; intestinal inflammation ; vascular permeability ; VEGF ; Medicine (General) ; R5-920 ; Genetics ; QH426-470
    Subject code 610
    Language English
    Publishing date 2022-05-01T00:00:00Z
    Publisher Wiley
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes.

    Zeng, Fa-Min / Li, Ying-Wen / Deng, Zhao-Hua / He, Jian-Zhong / Li, Wei / Wang, Lijie / Lyu, Ting / Li, Zhanyu / Mei, Chaoming / Yang, Meiling / Dong, Yingying / Jiang, Guan-Min / Li, Xiaofeng / Huang, Xi / Xiao, Fei / Liu, Ye / Shan, Hong / He, Huanhuan

    EMBO molecular medicine

    2022  Volume 14, Issue 5, Page(s) e14844

    Abstract: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can cause gastrointestinal (GI) symptoms that often correlate with the severity of COVID-19. Here, we explored the pathogenesis underlying the intestinal inflammation in COVID-19. Plasma VEGF ... ...

    Abstract Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can cause gastrointestinal (GI) symptoms that often correlate with the severity of COVID-19. Here, we explored the pathogenesis underlying the intestinal inflammation in COVID-19. Plasma VEGF level was particularly elevated in patients with GI symptoms and significantly correlated with intestinal edema and disease progression. Through an animal model mimicking intestinal inflammation upon stimulation with SARS-CoV-2 spike protein, we further revealed that VEGF was over-produced in the duodenum prior to its ascent in the circulation. Mechanistically, SARS-CoV-2 spike promoted VEGF production through activating the Ras-Raf-MEK-ERK signaling in enterocytes, but not in endothelium, and inducing permeability and inflammation. Blockage of the ERK/VEGF axis was able to rescue vascular permeability and alleviate intestinal inflammation in vivo. These findings provide a mechanistic explanation and therapeutic targets for the GI symptoms of COVID-19.
    MeSH term(s) Animals ; COVID-19 ; Enterocytes/metabolism ; Humans ; Inflammation/metabolism ; SARS-CoV-2 ; Spike Glycoprotein, Coronavirus ; Vascular Endothelial Growth Factor A
    Chemical Substances Spike Glycoprotein, Coronavirus ; Vascular Endothelial Growth Factor A ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2022-04-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2467145-9
    ISSN 1757-4684 ; 1757-4676
    ISSN (online) 1757-4684
    ISSN 1757-4676
    DOI 10.15252/emmm.202114844
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma.

    Zeng, Fa-Min / He, Jian-Zhong / Wang, Shao-Hong / Liu, De-Kai / Xu, Xiu-E / Wu, Jian-Yi / Li, En-Min / Xu, Li-Yan

    BioMed research international

    2019  Volume 2019, Page(s) 9828637

    Abstract: To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have ...

    Abstract To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have superiority over the use of single biomarkers. Our previous studies have identified the crucial role of ezrin in ESCC progression, which prompted us to hypothesize that ezrin-associated proteins contribute to the pathobiology of ESCC. Herein, we explored the clinical value of a molecular model constructed based on ezrin-associated proteins in ESCC patients. We revealed that the ezrin-associated proteins (MYC, PDIA3, and ITGA5B1) correlated with the overall survival (OS) and disease-free survival (DFS) of patients with ESCC. High expression of MYC was associated with advanced pTNM-stage (
    MeSH term(s) Biomarkers, Tumor/genetics ; Esophageal Squamous Cell Carcinoma/diagnosis ; Esophageal Squamous Cell Carcinoma/drug therapy ; Esophageal Squamous Cell Carcinoma/genetics ; Esophageal Squamous Cell Carcinoma/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Models, Genetic ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Predictive Value of Tests ; Prognosis
    Chemical Substances Biomarkers, Tumor ; Neoplasm Proteins
    Language English
    Publishing date 2019-11-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2698540-8
    ISSN 2314-6141 ; 2314-6133
    ISSN (online) 2314-6141
    ISSN 2314-6133
    DOI 10.1155/2019/9828637
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Promotion of rs3746804 (p. L267P) polymorphism to intracellular SLC52A3a trafficking and riboflavin transportation in esophageal cancer cells

    Long, Lin / Pang, Xiao-Xiao / Zeng, Fa-Min / Zhan, Xiu-Hui / Xie, Ying-Hua / Pan, Feng / Wang, Wei / Liao, Lian-Di / Xu, Xiu-E. / Li, Bin / Wang, Li-Dong / Chang, Zhi-Jie / Li, En-Min / Xu, Li-Yan

    Amino acids. 2021 Aug., v. 53, no. 8

    2021  

    Abstract: Riboflavin is an essential micronutrient for normal cellular growth and function. Lack of dietary riboflavin is associated with an increased risk for esophageal squamous cell carcinoma (ESCC). Previous studies have identified that the human riboflavin ... ...

    Abstract Riboflavin is an essential micronutrient for normal cellular growth and function. Lack of dietary riboflavin is associated with an increased risk for esophageal squamous cell carcinoma (ESCC). Previous studies have identified that the human riboflavin transporter SLC52A3a isoform (encoded by SLC52A3) plays a prominent role in esophageal cancer cell riboflavin transportation. Furthermore, SLC52A3 gene single nucleotide polymorphisms rs3746804 (T>C, L267P) and rs3746803 (C >T, T278M) are associated with ESCC risk. However, whether SLC52A3a (p.L267P) and (p.T278M) act in riboflavin transportation in esophageal cancer cell remains inconclusive. Here, we constructed the full-length SLC52A3a protein fused to green fluorescent protein (GFP-SLC52A3a-WT and mutants L267P, T278M, and L267P/T278M). It was confirmed by immunofluorescence-based confocal microscopy that SLC52A3a-WT, L267P, T278M, and L267P/T278M expressed in cell membrane, as well as in a variety of intracellular punctate structures. The live cell confocal imaging showed that SLC52A3a-L267P and L267P/T278M increased the intracellular trafficking of SLC52A3a in ESCC cells. Fluorescence recovery after photobleaching of GFP-tagged SLC52A3a meant that intracellular trafficking of SLC52A3a-L267P and L267P/T278M was rapid dynamics process, leading to its stronger ability to transport riboflavin. Taken together, the above results indicated that the rs3746804 (p.L267P) polymorphism promoted intracellular trafficking of SLC52A3a and riboflavin transportation in ESCC cells.
    Keywords cell growth ; cell membranes ; confocal microscopy ; esophageal neoplasms ; fluorescence recovery after photobleaching ; genes ; green fluorescent protein ; humans ; neoplasm cells ; riboflavin ; risk ; squamous cell carcinoma ; transportation
    Language English
    Dates of publication 2021-08
    Size p. 1197-1209.
    Publishing place Springer Vienna
    Document type Article
    ZDB-ID 1121341-3
    ISSN 1438-2199 ; 0939-4451
    ISSN (online) 1438-2199
    ISSN 0939-4451
    DOI 10.1007/s00726-021-03025-4
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Promotion of rs3746804 (p. L267P) polymorphism to intracellular SLC52A3a trafficking and riboflavin transportation in esophageal cancer cells.

    Long, Lin / Pang, Xiao-Xiao / Zeng, Fa-Min / Zhan, Xiu-Hui / Xie, Ying-Hua / Pan, Feng / Wang, Wei / Liao, Lian-Di / Xu, Xiu-E / Li, Bin / Wang, Li-Dong / Chang, Zhi-Jie / Li, En-Min / Xu, Li-Yan

    Amino acids

    2021  Volume 53, Issue 8, Page(s) 1197–1209

    Abstract: Riboflavin is an essential micronutrient for normal cellular growth and function. Lack of dietary riboflavin is associated with an increased risk for esophageal squamous cell carcinoma (ESCC). Previous studies have identified that the human riboflavin ... ...

    Abstract Riboflavin is an essential micronutrient for normal cellular growth and function. Lack of dietary riboflavin is associated with an increased risk for esophageal squamous cell carcinoma (ESCC). Previous studies have identified that the human riboflavin transporter SLC52A3a isoform (encoded by SLC52A3) plays a prominent role in esophageal cancer cell riboflavin transportation. Furthermore, SLC52A3 gene single nucleotide polymorphisms rs3746804 (T>C, L267P) and rs3746803 (C >T, T278M) are associated with ESCC risk. However, whether SLC52A3a (p.L267P) and (p.T278M) act in riboflavin transportation in esophageal cancer cell remains inconclusive. Here, we constructed the full-length SLC52A3a protein fused to green fluorescent protein (GFP-SLC52A3a-WT and mutants L267P, T278M, and L267P/T278M). It was confirmed by immunofluorescence-based confocal microscopy that SLC52A3a-WT, L267P, T278M, and L267P/T278M expressed in cell membrane, as well as in a variety of intracellular punctate structures. The live cell confocal imaging showed that SLC52A3a-L267P and L267P/T278M increased the intracellular trafficking of SLC52A3a in ESCC cells. Fluorescence recovery after photobleaching of GFP-tagged SLC52A3a meant that intracellular trafficking of SLC52A3a-L267P and L267P/T278M was rapid dynamics process, leading to its stronger ability to transport riboflavin. Taken together, the above results indicated that the rs3746804 (p.L267P) polymorphism promoted intracellular trafficking of SLC52A3a and riboflavin transportation in ESCC cells.
    MeSH term(s) Biological Transport ; Cell Line, Tumor ; Esophageal Neoplasms/metabolism ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma/metabolism ; Esophageal Squamous Cell Carcinoma/pathology ; Exome ; Green Fluorescent Proteins/genetics ; Humans ; Membrane Transport Proteins/genetics ; Polymerase Chain Reaction/methods ; Polymorphism, Single Nucleotide ; Riboflavin/metabolism
    Chemical Substances Membrane Transport Proteins ; SLC52A3 protein, human ; Green Fluorescent Proteins (147336-22-9) ; Riboflavin (TLM2976OFR)
    Language English
    Publishing date 2021-07-05
    Publishing country Austria
    Document type Journal Article
    ZDB-ID 1121341-3
    ISSN 1438-2199 ; 0939-4451
    ISSN (online) 1438-2199
    ISSN 0939-4451
    DOI 10.1007/s00726-021-03025-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: FSCC: Few-Shot Learning for Macromolecule Classification Based on Contrastive Learning and Distribution Calibration in Cryo-Electron Tomography.

    Gao, Shan / Zeng, Xiangrui / Xu, Min / Zhang, Fa

    Frontiers in molecular biosciences

    2022  Volume 9, Page(s) 931949

    Abstract: Cryo-electron tomography (Cryo-ET) is an emerging technology for three-dimensional (3D) visualization of macromolecular structures in the near-native state. To recover structures of macromolecules, millions of diverse macromolecules captured in tomograms ...

    Abstract Cryo-electron tomography (Cryo-ET) is an emerging technology for three-dimensional (3D) visualization of macromolecular structures in the near-native state. To recover structures of macromolecules, millions of diverse macromolecules captured in tomograms should be accurately classified into structurally homogeneous subsets. Although existing supervised deep learning-based methods have improved classification accuracy, such trained models have limited ability to classify novel macromolecules that are unseen in the training stage. To adapt the trained model to the macromolecule classification of a novel class, massive labeled macromolecules of the novel class are needed. However, data labeling is very time-consuming and labor-intensive. In this work, we propose a novel few-shot learning method for the classification of novel macromolecules (named FSCC). A two-stage training strategy is designed in FSCC to enhance the generalization ability of the model to novel macromolecules. First, FSCC uses contrastive learning to pre-train the model on a sufficient number of labeled macromolecules. Second, FSCC uses distribution calibration to re-train the classifier, enabling the model to classify macromolecules of novel classes (unseen class in the pre-training). Distribution calibration transfers learned knowledge in the pre-training stage to novel macromolecules with limited labeled macromolecules of novel class. Experiments were performed on both synthetic and real datasets. On the synthetic datasets, compared with the state-of-the-art (SOTA) method based on supervised deep learning, FSCC achieves competitive performance. To achieve such performance, FSCC only needs five labeled macromolecules per novel class. However, the SOTA method needs 1100 ∼ 1500 labeled macromolecules per novel class. On the real datasets, FSCC improves the accuracy by 5% ∼ 16% when compared to the baseline model. These demonstrate good generalization ability of contrastive learning and calibration distribution to classify novel macromolecules with very few labeled macromolecules.
    Language English
    Publishing date 2022-07-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2022.931949
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: FSCC

    Shan Gao / Xiangrui Zeng / Min Xu / Fa Zhang

    Frontiers in Molecular Biosciences, Vol

    Few-Shot Learning for Macromolecule Classification Based on Contrastive Learning and Distribution Calibration in Cryo-Electron Tomography

    2022  Volume 9

    Abstract: Cryo-electron tomography (Cryo-ET) is an emerging technology for three-dimensional (3D) visualization of macromolecular structures in the near-native state. To recover structures of macromolecules, millions of diverse macromolecules captured in tomograms ...

    Abstract Cryo-electron tomography (Cryo-ET) is an emerging technology for three-dimensional (3D) visualization of macromolecular structures in the near-native state. To recover structures of macromolecules, millions of diverse macromolecules captured in tomograms should be accurately classified into structurally homogeneous subsets. Although existing supervised deep learning–based methods have improved classification accuracy, such trained models have limited ability to classify novel macromolecules that are unseen in the training stage. To adapt the trained model to the macromolecule classification of a novel class, massive labeled macromolecules of the novel class are needed. However, data labeling is very time-consuming and labor-intensive. In this work, we propose a novel few-shot learning method for the classification of novel macromolecules (named FSCC). A two-stage training strategy is designed in FSCC to enhance the generalization ability of the model to novel macromolecules. First, FSCC uses contrastive learning to pre-train the model on a sufficient number of labeled macromolecules. Second, FSCC uses distribution calibration to re-train the classifier, enabling the model to classify macromolecules of novel classes (unseen class in the pre-training). Distribution calibration transfers learned knowledge in the pre-training stage to novel macromolecules with limited labeled macromolecules of novel class. Experiments were performed on both synthetic and real datasets. On the synthetic datasets, compared with the state-of-the-art (SOTA) method based on supervised deep learning, FSCC achieves competitive performance. To achieve such performance, FSCC only needs five labeled macromolecules per novel class. However, the SOTA method needs 1100 ∼ 1500 labeled macromolecules per novel class. On the real datasets, FSCC improves the accuracy by 5% ∼ 16% when compared to the baseline model. These demonstrate good generalization ability of contrastive learning and calibration distribution to classify novel macromolecules with ...
    Keywords few-shot learning ; cryo-ET ; macromolecule classification ; contrastive learning ; distribution calibration ; Biology (General) ; QH301-705.5
    Subject code 006
    Language English
    Publishing date 2022-07-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma

    Fa-Min Zeng / Jian-Zhong He / Shao-Hong Wang / De-kai Liu / Xiu-E. Xu / Jian-Yi Wu / En-Min Li / Li-Yan Xu

    BioMed Research International, Vol

    2019  Volume 2019

    Abstract: To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have ...

    Abstract To precisely predict the clinical outcome and determine the optimal treatment options for patients with esophageal squamous cell carcinoma (ESCC) remains challenging. Prognostic models based on multiple molecular markers of tumors have been shown to have superiority over the use of single biomarkers. Our previous studies have identified the crucial role of ezrin in ESCC progression, which prompted us to hypothesize that ezrin-associated proteins contribute to the pathobiology of ESCC. Herein, we explored the clinical value of a molecular model constructed based on ezrin-associated proteins in ESCC patients. We revealed that the ezrin-associated proteins (MYC, PDIA3, and ITGA5B1) correlated with the overall survival (OS) and disease-free survival (DFS) of patients with ESCC. High expression of MYC was associated with advanced pTNM-stage (P=0.011), and PDIA3 and ITGA5B1 were correlated with both lymph node metastasis (PDIA3: P<0.001; ITGA5B1: P=0.001) and pTNM-stage (PDIA3: P=0.001; ITGA5B1: P=0.009). Furthermore, we found that, compared with the current TNM staging system, the molecular model elicited from the expression of MYC, PDIA3, and ITGA5B1 shows higher accuracy in predicting OS (P<0.001) or DFS (P<0.001) in ESCC patients. Moreover, ROC and regression analysis demonstrated that this model was an independent predictor for OS and DFS, which could also help determine a subgroup of ESCC patients that may benefit from chemoradiotherapy. In conclusion, our study has identified a novel molecular prognosis model, which may serve as a complement for current clinical risk stratification approaches and provide potential therapeutic targets for ESCC treatment.
    Keywords Medicine ; R
    Subject code 616
    Language English
    Publishing date 2019-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top